Read + Share
Naert T, Tulkens D, Van Nieuwenhuysen T, Przybyl J, et al. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo
dependency mapping. Proc Natl Acad Sci U S A 2021;118.
PMID: 34789568
|
 |
|
Naert T, Tulkens D, Van Nieuwenhuysen T, Przybyl J, et al. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo
dependency mapping. Proc Natl Acad Sci U S A 2021;118.
PMID: 34789568
|
|
|
|